ZEISS ARTEVO Gets NMPA Approval for China Ophthalmology Market
CompanyMedical Device

ZEISS ARTEVO Gets NMPA Approval for China Ophthalmology Market

CompanyDrug

Venglustat Gaucher: Sanofi Meets Primary Endpoint in Phase 3 LEAP2MONO Study

CompanyDeals

Arctic Vision-Mdco Technology Merger Builds Ophthalmology Platform

Company

Eli Lilly to Invest $3.5B in Pennsylvania Plant for Retatrutide Production

Eli Lilly Mounjaro Fails to Win EU Approval for HFpEF Heart Failure Indication
CompanyDrug

Eli Lilly Mounjaro Fails to Win EU Approval for HFpEF Heart Failure Indication

Imfinzi Gastric Cancer: AstraZeneca Secures CHMP Recommendation
CompanyDrug

Imfinzi Gastric Cancer: AstraZeneca Secures CHMP Recommendation

Chiesi's Juxtapid Wins NMPA Approval for Rare Cholesterol Disorder in China
CompanyDrug

Chiesi’s Juxtapid Wins NMPA Approval for Rare Cholesterol Disorder in China

CompanyDeals

SanegeneBio Partners with Genentech on RNAi Therapy in $1.7B Deal

CompanyDeals

Zonsen Peplib Signs Eli Lilly Deal After Novartis Partnership

Novartis Cosentyx Wins NMPA Approval for Non-Radiographic Axial Spondyloarthritis
CompanyDrug

Novartis Cosentyx Wins NMPA Approval for Non-Radiographic Axial Spondyloarthritis

CompanyDeals

WuXi Biologics Partners with Vertex on Trispecific T-Cell Engager for Autoimmune Diseases

Policy / Regulatory

NMPA Releases 101st Batch of Generic Reference Drugs